SARS-CoV-2 Orf9b suppresses type I interferon responses by targeting TOM70.

Jiang HW, Zhang HN, Meng QF, Xie J, Li Y, Chen H, Zheng YX, Wang XN, Qi H, Zhang J, Wang PH, Han ZG, Tao SC. · 2020

Read SARS-CoV-2 Orf9b suppresses type I interferon responses by targeting TOM70. by Jiang HW, Zhang HN, Meng QF, Xie J, Li Y, Chen H, Zheng YX, Wang XN, Qi H, Zhang J, Wang PH, Han ZG, Tao SC. (2020) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/europmc-pmc7387808.txt.

Description

Jiang and co-authors report how a small SARS-CoV-2 protein disarms the cell's alarm system, in Cellular and Molecular Immunology. As of July 2020 no effective drug or vaccine existed, so viral weak points were precious. The protein Orf9b, they found, settles on the membrane of mitochondria, the cell's power stations.

There it binds TOM70, a helper in the chain that switches on type I interferon, the cell's main antiviral signal. With Orf9b attached, interferon responses are suppressed. Adding extra TOM70 largely rescued the response in their tests. The authors propose the Orf9b-TOM70 contact as a drug target: block the handshake and the alarm sounds again. Readers get a precise molecular sabotage story.

Catalog record

CREATORJiang HW, Zhang HN, Meng QF, Xie J, Li Y, Chen H, Zheng YX, Wang XN, Qi H, Zhang J, Wang PH, Han ZG, Tao SC.
YEAR2020
COLLECTIONPAPERS
FORMATTXT
FILE SIZE13 KB
LICENSECC BY 4.0
RIGHTSCC BY
SOURCEEurope PMC

Source: https://europepmc.org/articles/PMC7387808

Browse the full library · About the Tower of Babel